Location History:
- Gava Barcelone, ES (2023)
- Gava Barcelona, ES (2024)
Company Filing History:
Years Active: 2023-2025
Title: Innovations by Laurence Lachamp
Introduction
Laurence Lachamp is a notable inventor based in Gava, Barcelona, Spain. He has made significant contributions to the field of injectable presentations and medical devices. With a total of 3 patents, his work focuses on improving the delivery of medications through innovative syringe designs.
Latest Patents
One of his latest patents is for "Injectable presentations, syringes and compositions with sustained and/or controlled release of lanreotide." This invention relates to novel injectable presentations, kits, or syringes that comprise a composition with sustained or controlled release of lanreotide or one of its salts. The compositions are packaged in a syringe with a diameter greater than 3.00 mm and equipped with a needle that has an outer diameter no greater than 1.00 mm. Another significant patent is for a "Syringe-connector device for the separate administration of controlled quantities of at least two products in a single injection." This invention features a syringe-connector device that includes a hollow plunger with an open inner channel, allowing for the separate administration of controlled quantities of at least two products in a single injection.
Career Highlights
Throughout his career, Laurence Lachamp has worked with various companies, including Edix S.A. and Edix-o Sarl. His innovative approach to medical devices has positioned him as a key player in the industry.
Collaborations
Laurence has collaborated with several professionals, including Tabatha Bourgois and Frederic Lacombe. These collaborations have contributed to the development of his patented inventions.
Conclusion
Laurence Lachamp's contributions to the field of injectable presentations and medical devices highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to advancing medical technology for better patient outcomes.